Alok Dalal
Stock Analyst at Jefferies
(3.09)
# 2,690
Out of 4,662 analysts
91
Total ratings
54.5%
Success rate
4.5%
Average return
Main Sectors:
Stocks Rated by Alok Dalal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Maintained: Buy | ₹9,700 → ₹10,350 | ₹8,712 | +18.80% | 5 | Aug 17, 2026 | |
| NSE: EMCURE Emcure Pharmaceuticals Limited | Maintained: Buy | ₹2,100 → ₹2,320 | ₹1,881 | +23.34% | 9 | Aug 11, 2026 | |
| NSE: ENTERO Entero Healthcare Solutions Limited | Maintained: Buy | ₹1,500 → ₹1,800 | ₹1,394 | +29.11% | 7 | Aug 11, 2026 | |
| NSE: GLAND Gland Pharma Limited | Upgraded: Buy | ₹2,080 → ₹3,350 | ₹2,838 | +18.03% | 5 | Aug 11, 2026 | |
| NSE: SAILIFE Sai Life Sciences Limited | Maintained: Buy | ₹1,270 → ₹1,610 | ₹1,425 | +12.98% | 5 | Aug 11, 2026 | |
| NSE: COHANCE Cohance Lifesciences Limited | Maintained: Sell | ₹300.00 → ₹350.00 | ₹444.95 | -21.34% | 2 | Aug 6, 2026 | |
| NSE: MEDANTA Global Health Limited | Maintained: Buy | ₹1,500 → ₹1,660 | ₹1,429 | +16.17% | 6 | Aug 4, 2026 | |
| NSE: MANKIND Mankind Pharma Limited | Maintained: Buy | ₹3,000 → ₹3,220 | ₹2,391 | +34.70% | 7 | Jul 31, 2026 | |
| NSE: CIPLA Cipla Limited | Maintained: Sell | ₹1,170 | ₹1,422 | -17.72% | 8 | Jul 28, 2026 | |
| NSE: LAURUSLABS Laurus Labs Limited | Maintained: Hold | ₹1,100 → ₹1,700 | ₹1,806 | -5.84% | 4 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹6,000 → ₹6,500 | ₹5,381 | +20.81% | 5 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,380 → ₹1,500 | ₹996.00 | n/a | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹2,400 → ₹2,250 | ₹2,223 | n/a | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,210 → ₹1,100 | ₹1,170 | n/a | 2 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,620 → ₹1,700 | ₹1,590 | n/a | 3 | May 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,350 → ₹1,150 | ₹1,110 | n/a | 3 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹6,280 → ₹6,200 | ₹8,531 | n/a | 2 | May 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹260.00 | ₹209.55 | n/a | 1 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,850 → ₹3,140 | ₹3,690 | n/a | 2 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹890.00 → ₹650.00 | ₹397.90 | n/a | 2 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹860.00 → ₹850.00 | ₹908.75 | n/a | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,260 → ₹2,265 | ₹1,899 | n/a | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | ₹400.00 | ₹414.80 | n/a | 1 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $68 → $12 | $12.11 | n/a | 4 | Jan 30, 2024 |
Apollo Hospitals Enterprise Limited
Aug 17, 2026
Maintained: Buy
Price Target: ₹9,700 → ₹10,350
Current: ₹8,712
Upside: +18.80%
Emcure Pharmaceuticals Limited
Aug 11, 2026
Maintained: Buy
Price Target: ₹2,100 → ₹2,320
Current: ₹1,881
Upside: +23.34%
Entero Healthcare Solutions Limited
Aug 11, 2026
Maintained: Buy
Price Target: ₹1,500 → ₹1,800
Current: ₹1,394
Upside: +29.11%
Gland Pharma Limited
Aug 11, 2026
Upgraded: Buy
Price Target: ₹2,080 → ₹3,350
Current: ₹2,838
Upside: +18.03%
Sai Life Sciences Limited
Aug 11, 2026
Maintained: Buy
Price Target: ₹1,270 → ₹1,610
Current: ₹1,425
Upside: +12.98%
Cohance Lifesciences Limited
Aug 6, 2026
Maintained: Sell
Price Target: ₹300.00 → ₹350.00
Current: ₹444.95
Upside: -21.34%
Global Health Limited
Aug 4, 2026
Maintained: Buy
Price Target: ₹1,500 → ₹1,660
Current: ₹1,429
Upside: +16.17%
Mankind Pharma Limited
Jul 31, 2026
Maintained: Buy
Price Target: ₹3,000 → ₹3,220
Current: ₹2,391
Upside: +34.70%
Cipla Limited
Jul 28, 2026
Maintained: Sell
Price Target: ₹1,170
Current: ₹1,422
Upside: -17.72%
Laurus Labs Limited
Jul 28, 2026
Maintained: Hold
Price Target: ₹1,100 → ₹1,700
Current: ₹1,806
Upside: -5.84%
May 29, 2026
Maintained: Buy
Price Target: ₹6,000 → ₹6,500
Current: ₹5,381
Upside: +20.81%
Aug 14, 2025
Maintained: Buy
Price Target: ₹1,380 → ₹1,500
Current: ₹996.00
Upside: n/a
Aug 7, 2025
Upgraded: Buy
Price Target: ₹2,400 → ₹2,250
Current: ₹2,223
Upside: n/a
Jul 24, 2025
Maintained: Sell
Price Target: ₹1,210 → ₹1,100
Current: ₹1,170
Upside: n/a
May 31, 2025
Maintained: Hold
Price Target: ₹1,620 → ₹1,700
Current: ₹1,590
Upside: n/a
May 21, 2025
Maintained: Buy
Price Target: ₹1,350 → ₹1,150
Current: ₹1,110
Upside: n/a
May 18, 2025
Maintained: Hold
Price Target: ₹6,280 → ₹6,200
Current: ₹8,531
Upside: n/a
May 15, 2025
Maintained: Buy
Price Target: ₹260.00
Current: ₹209.55
Upside: n/a
Apr 30, 2025
Maintained: Buy
Price Target: ₹2,850 → ₹3,140
Current: ₹3,690
Upside: n/a
Apr 25, 2025
Maintained: Hold
Price Target: ₹890.00 → ₹650.00
Current: ₹397.90
Upside: n/a
Feb 10, 2025
Maintained: Buy
Price Target: ₹860.00 → ₹850.00
Current: ₹908.75
Upside: n/a
Jan 31, 2025
Maintained: Buy
Price Target: ₹2,260 → ₹2,265
Current: ₹1,899
Upside: n/a
Jan 6, 2025
Upgraded: Hold
Price Target: ₹400.00
Current: ₹414.80
Upside: n/a
Jan 30, 2024
Downgraded: Sell
Price Target: $68 → $12
Current: $12.11
Upside: n/a